Research programme: vaccines - Imaxio
Alternative Names: AVD 177Latest Information Update: 16 Jul 2016
At a glance
- Originator Imaxio
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Malaria; Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in France (Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malaria in France (Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in France (Injection)